$93.3 Million is the total value of Privium Fund Management (UK) Ltd's 55 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
TECK | TECK RESOURCES LTDcl b | $1,236,000 | +8.1% | 49,600 | 0.0% | 1.32% | +66.5% | |
COPX | GLOBAL X FDSglobal x copper | $752,000 | -8.0% | 22,000 | 0.0% | 0.81% | +41.7% | |
CLOU | GLOBAL X FDS | $703,000 | +2.6% | 24,000 | 0.0% | 0.75% | +58.1% | |
MYGN | MYRIAD GENETICS INC | $452,000 | +5.6% | 14,000 | 0.0% | 0.48% | +62.8% | |
BATT | AMPLIFY ETF TRamplify lithium | $448,000 | -3.4% | 26,000 | 0.0% | 0.48% | +48.6% | |
ACRX | ACELRX PHARMACEUTICALS INC | $14,000 | -26.3% | 14,099 | 0.0% | 0.02% | +15.4% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-11-05
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
ALASKA AIR GROUP INC | 11 | Q3 2023 | 2.6% |
CONTROLADORA VUELA COMP DE A | 11 | Q3 2023 | 1.7% |
ALPHABET INC | 10 | Q3 2023 | 10.1% |
COPA HOLDINGS SA | 9 | Q3 2023 | 1.8% |
DELTA AIR LINES INC DEL | 8 | Q3 2023 | 2.7% |
SPDR GOLD TR | 8 | Q4 2022 | 1.6% |
ACELRX PHARMACEUTICALS INC | 8 | Q3 2022 | 0.0% |
ISHARES INC | 7 | Q3 2023 | 5.4% |
TECK RESOURCES LTD | 7 | Q3 2022 | 1.9% |
ISHARES TR | 7 | Q3 2023 | 2.1% |
View Privium Fund Management (UK) Ltd's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-04-29 |
13F-HR | 2024-02-13 |
13F-HR | 2023-11-06 |
13F-HR | 2023-07-26 |
13F-HR | 2023-05-03 |
13F-HR | 2023-02-09 |
13F-HR | 2022-11-01 |
13F-HR | 2022-07-28 |
13F-HR | 2022-05-10 |
13F-HR/A | 2022-03-25 |
View Privium Fund Management (UK) Ltd's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.